PacBio Patent Infringement Case Transferred from Delaware to California

The patent infringement case against biotechnology firm Pacific Biosciences of California Inc. has been moved from a Delaware federal court to California. According to the judgement, there were insufficient reasons to support maintaining the case proceedings in Delaware. Pacific Biosciences of California Inc., commonly known as PacBio, is a biotechnology company that’s profusely involved in…

Read More

Mandatory Litigation Funding Disclosure Vital for Impartial Justice, Argues Legal Scholar

In a recent opinion piece, renowned legal scholar David Levitt argues that the disclosure of third-party litigation funding should be made mandatory across all cases. This call to action comes on the back of the Appellate Rules Committee’s decision to defer the issue. Third-party litigation funding, wherein a third party unconnected to the lawsuit provides…

Read More

UK Supreme Court Ruling Disrupts Litigation Funding Industry: Reassessing Damages-Based Agreements

In a recent ruling that has sent ripples across the UK’s litigation funding industry, the UK Supreme Court declared that a large number of litigation funding agreements are in fact damages-based agreements (DBAs), and hence, are subject to comply with the relevant regulations. This ruling has caused concern among funders as they scramble to reassess…

Read More

Mastercard’s Track-and-Trace Lawsuit Revived: Implications for Financial and Cannabis Industries

In a recent development in the financial industry, Mastercard’s warning and track-and-trace lawsuit has been revived. Without revealing further details at this stage, this development indicates potential implications across the board, particularly in the financial services and payment process sectors. Legal professionals and other stakeholders are awaiting further updates with bated breath. This comes amid…

Read More

Mandatory Disclosure Debate: Enhanced Transparency for Third-Party Litigation Funding

The status quo regarding mandatory disclosure of third-party litigation funding is under scrutiny. Legally vested committees are currently considering whether to make such disclosure obligatory. David Levitt, esteemed legal expert, recently pushed the conversation forward on the matter, advocating for the necessity of this mandate to fortify the even-handed administration of justice across all litigations….

Read More

Singapore Executes Second Drug Trafficker in a Week Amid International Criticism

On Thursday, Singaporean authorities carried out the execution of 39-year-old former delivery driver, Mohamed Shalleh Bin Abdul Latiff, for the trafficking of 54.04 grams of diamorphine, a controlled substance. This amount exceeds by four times the threshold required to impose the mandatory death penalty as stated under Singapore’s Misuse of Drugs Act. This marks the…

Read More

Legal Tech Firms Bolster Employment Contracts Amid Gen AI Proprietary Information Concerns

In the dynamic sphere of legal technology, securing company secrets has become increasingly paramount, especially in the unfolding era of generative artificial intelligence (Gen AI). In this context, many firms are turning a spotlight on their employment contracts to ensure stringent protection of their confidential assets. Last month, Kira Systems, an entity that specializes in…

Read More

Philadelphia Law Firm Schnader Harrison Set to Dissolve After Nearly 90-Year Legacy

The long-standing Philadelphia law firm, Schnader Harrison Segal & Lewis, is set to cease operations after almost 90 years. The firm’s litigation partner and generan counsel, Keith Whitson, has confirmed that a dissolution plan is being organized in collaboration with the firm’s stakeholders and bank. The exact timeline for voting and finalizing this plan remains…

Read More

Envision Healthcare Files for Chapter 11, Affecting Emergency Medicine Services Nationwide

Envision Healthcare Corp., along with its wholly-owned subsidiaries, has recently filed for voluntary Chapter 11 petitions at the U.S. Bankruptcy Court for the Southern District of Texas. This information is detailed in the case documented under In re: Envision Healthcare Corp., Docket No. 4:23-bk-90342 (Bankr. S.D. Tex. May 15, 2023). Envision is known for being…

Read More

Federal Circuit Delivers Pivotal Ruling in United Therapeutics v. Liquidia Pharmaceuticals Patent Case

In the continually evolving arena of patent law, the third week of July 2023 has seen pivotal advancement in patent cases adjudicated by the Federal Circuit. One such central case involved the United Therapeutics Corp. and Liquidia Technologies, Inc. (Nos. 2022-2217, 2023-1021, Fed. Cir. (D. Del.) July 24, 2023). The case merits attention due to…

Read More

Navigating Georgia’s Construction Arbitration: Procedural Issues Impacting Outcomes

Arbitration has traditionally served as an alternative to litigation in the field of construction disputes. Many construction agreements incorporate clauses that reference arbitration, with several of these bringing into play particular rules set by designated arbitration providers. Lately, though, procedural issues within this area have been brought to light, particularly pertaining to the state of…

Read More

Distressed M&A Surge Looms: Preparing for Complex Transactions in Retail Sector

As the globe continues to navigate an uncertain economic landscape, with challenges such as climbing interest rates, inflation and the looming threat of a potential recession, the Mergers and Acquisitions (M&A) activity landscape is also adjusting. Industry experts suggest that the future may include an increased prevalence of transactions involving distressed targets, particularly within the…

Read More

FTC Issues Civil Investigative Demand to OpenAI: Implications for Tech Industry Compliance

In an unexpected turn of events, The Washington Post uncovered on July 13, 2023, that the Federal Trade Commission (FTC) has issued a Civil Investigative Demand (CID)—which acts much like a pre-litigation subpoena—directed at OpenAI, LLC. This company is a renowned developer of technologies like ChatGPT and DALL-E. This surprising news has reverberated throughout the…

Read More

Court Ruling Bolsters Patent Protection for “Therapeutically Effective” Dose Claims in Medical Treatments

In a recent ruling by the U.S. Court of Appeals for the Federal Circuit, it has been determined that a claim to a treatment method for pulmonary hypertension cannot be invalidated for lacking enablement or written description. The case at hand is United Therapeutics Corporation v. Liquidia Technologies, Inc. The court declared that the claims,…

Read More

Rising Trend in Section 220 Books and Records Requests: Navigating Corporate Transparency and Legal Challenges

Section 220 of the Delaware General Corporation Law sets a precedent that any stockholder in a corporation has a right to inspect the books and records of that corporation. Utilized as a legal tool, a books and records request allows stockholders to gather necessary information ahead of filing a derivative lawsuit against officers and directors….

Read More

AI Integration in Sports: Transforming the Industry while Navigating Legal Implications

The advent of artificial intelligence (AI) is transforming various industries worldwide, and the sports sector is no exception to this technological revolution. Since the inception of the “Moneyball” theory, which heavily relied on technology to influence sports consumption and analysis by fans and experts, the sports industry has seen substantial developments in the use of…

Read More